Neurology Central

AAN 2017: Two clinical studies report promising data for new spinal muscular atrophy treatment

0

Two studies presented at the AAN Annual Meeting 2017 in Boston (MA, USA) have demonstrated positive results for nusinersen (Spinraza® Biogen (MA, USA) in the treatment of spinal muscular atrophy (SMA).

To view restricted content, please:
Share:

Leave A Comment